Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David Chin Yee (NPI 1740424563)

Field	Value
Entity Type	Individual
Organization	David Chin Yee
Address	1100 Johnson Ferry Rd
City	Atlanta
State	GA
ZIP	30342
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 23, 2009

Payer Source	Total Paid
Medicare	$2.9M
Medicaid	$0

Key Findings

This provider is a retina-focused ophthalmology practice whose Medicare revenue is heavily driven by intravitreal drug injections and retina imaging procedures. The top three Medicare codes — J2777, J0178, and J2778 — together account for 80.5% of the provider's total Medicare revenue, indicating a service mix concentrated on high-volume retina pharmacotherapy and associated intravitreal care rather than broad general ophthalmology visits or surgical retina as the dominant income source.

Medicare revenue for this provider totals $2.9M while there is no Medicaid billing on file, effectively making the practice single‑payer with Medicare as the material public payer. The absence of any Medicaid claims suggests limited participation in or negligible volume from state programs, so payer-mix risk for public payers is concentrated entirely in Medicare reimbursements.

J2777 (faricimab) is the single largest revenue source at $1.1M and represents 37.7% of the provider's Medicare revenue; the provider ranks #180 of 2039 nationally for this code (91st percentile). This placement indicates the provider has a typical, not uncommon volume for faricimab relative to peers, but it is still a core revenue engine for the practice.

J0178 (aflibercept) contributes $842.1K (28.7% of Medicare revenue) and the provider ranks #1070 of 3204 nationally (67th percentile), indicating a solid but not leading role in aflibercept administration versus national peers. Combined with the J2777 position, the provider relies on multiple anti‑VEGF/retina biologics rather than a single product, which may reflect formulary mix or clinical preferences in retinal disease management.

The provider also bills high volumes of retinal diagnostic imaging: 92134 accounts for $71.8K and the practice ranks #778 of 26868 providers nationally (97th percentile), labeled an “extreme outlier, far above typical national volume.” This suggests a strong capacity or focused workflow for OCT/retinal imaging and monitoring that supports the intensive injection service line.

Routine ophthalmology E/M volumes are present but not dominant: 92014 generated $83.3K (2.8% of Medicare revenue) and ranks in the 95th percentile nationally, a notably above‑typical volume. This pattern indicates the provider manages established medical retinal follow-ups alongside procedure visits rather than functioning solely as an injection-only clinic.

Procedure mix shows some higher‑complexity surgical retina activity but at modest scale: 67028 (intravitreal injection procedure code) has $161.3K (5.5% of Medicare revenue) with an 86th percentile rank, while 67108 (retinal detachment repair) appears rarely (13 claims, $12K). These data imply occasional surgical interventions are part of the practice scope, but the business is primarily procedural pharmacotherapy and imaging.

Tenure data show the provider’s NPI was enumerated on 2009-04-23, indicating roughly 17 years of registration. This multi‑year presence in the Medicare program supports established referral relationships and operational stability in retinal services within the Atlanta market.

On competitive standing across top codes, the provider is a modest to strong regional participant: for major drug codes the provider’s ranks span from the 67th to 91st percentiles (typical volumes) while for retinal imaging the provider is an extreme national outlier (97th percentile). Overall, the practice is not a dominant national leader in all retina drugs but is a high‑volume retinal imaging and injection center within the Medicare population.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	38,160	$30	$1.1M
J0178	Injection, aflibercept, 1 mg	1,220	$690	$842.1K
J2778	Injection, ranibizumab, 0.1 mg	2,310	$180	$417.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,680	$100	$161.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	970	$90	$83.3K
J3490	Unclassified drugs	50	$1,750	$78.8K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	480	$160	$74.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,320	$30	$71.8K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	260	$120	$30.6K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	340	$70	$22.8K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

David Chin Yee — 4 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	28	70	970	$680	$700.6K
J2777	6	40	14,100	$30	$524.3K
J2778	7	30	1,170	$180	$286.2K
67028	11	80	720	$90	$71.9K
J2781	6	10	320	$120	$43.6K
J7312	1	10	220	$160	$37.6K
67108	6	10	10	$1,260	$25.2K
J3490	29	50	50	$320	$19.8K
92014	31	850	130	$80	$19.7K
92012	57	380	90	$60	$10.5K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with David Chin Yee, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Stephanie Vanderveldt	GA	Ophthalmology Physician	$4.1M	$0
Sri Krishna Mukkamala	GA	Hospitalist Physician	$3.4M	$0
Alexander Bottini	GA	Retina Specialist (Ophthalmology) Physician	$3M	$0
Gregory Lee	GA	Ophthalmology Physician	$2.9M	$6.3K
Robert Stoltz	GA	Specialist	$2.6M	$0
Hyung Cho	GA	Ophthalmology Physician	$2.5M	$0
Sean Koh	GA	Ophthalmology Physician	$2.5M	$0
Atul Sharma	GA	Ophthalmology Physician	$2.2M	$0
Mark Rivellese	GA	Ophthalmology Physician	$2.1M	$0
Rahul Komati	IL	Retina Specialist (Ophthalmology) Physician	$1.9M	$0

Nearby Providers

Other providers in the same ZIP code as David Chin Yee, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Scottish Rite Children's Medical Center	GA	Pediatric Hematology & Oncology Physician	$0	$493.4M
Life Hope Labs LLC	GA	Clinical Medical Laboratory	$8.3M	$7.3K
The Childrens Center For Digestive Health Care LLC	GA	Pediatric Gastroenterology Physician	$0	$8.1M
Northside Emergency Associates, LLC	GA	Emergency Medicine Physician	$0	$6.1M
Atlanta Perinatal Consultants, LP	GA	Neonatal-Perinatal Medicine Physician	$0	$4.8M
Children's Orthopaedics Of Atlanta P.C.	GA	Orthopaedic Surgery Physician	$0	$2.5M
Paul Sutej	GA	Rheumatology Physician	$2.4M	$0
Childrens Care Pediatrics, PC	GA	Pediatrics Physician	$0	$1.9M
Resurgens Surgery Center LLC	GA	Ambulatory Surgical Clinic/Center	$1.7M	$0
Daniel Oh	GA	Retina Specialist (Ophthalmology) Physician	$1.7M	$0

David Chin Yee — Billing Profile & Reimbursement Data

Sign up for David Chin Yee — Billing Profile & Reimbursement Data policy alerts

David Chin Yee — Billing Profile & Reimbursement Data

Sign up for David Chin Yee — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References